Please use this identifier to cite or link to this item:
https://doi.org/10.3389/fonc.2021.626659
Title: | Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma | Authors: | Yu, Fenggang Syn, Nicholas L Lu, Yanan Chong, Qing Yun Lai, Junyun Tan, Wei Jian Goh, Boon Cher MacAry, Paul A Wang, Lingzhi Loh, Kwok Seng |
Keywords: | Science & Technology Life Sciences & Biomedicine Oncology Epstein-Barr virus nasopharyngeal carcinoma B cell lymphoma latent membrane protein 1 viral miRNAs |
Issue Date: | 7-Apr-2021 | Publisher: | FRONTIERS MEDIA SA | Citation: | Yu, Fenggang, Syn, Nicholas L, Lu, Yanan, Chong, Qing Yun, Lai, Junyun, Tan, Wei Jian, Goh, Boon Cher, MacAry, Paul A, Wang, Lingzhi, Loh, Kwok Seng (2021-04-07). Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma. FRONTIERS IN ONCOLOGY 11. ScholarBank@NUS Repository. https://doi.org/10.3389/fonc.2021.626659 | Abstract: | © Copyright © 2021 Yu, Syn, Lu, Chong, Lai, Tan, Goh, MacAry, Wang and Loh. Epstein-Barr virus (EBV)—the prototypical human tumor virus—is responsible for 1–2% of the global cancer burden, but divergent strains seem to exist in different geographical regions with distinct predilections for causing lymphoid or epithelial malignancies. Here we report the establishment and characterization of Yu103, an Asia Pacific EBV strain with a highly remarkable provenance of being derived from nasopharyngeal carcinoma biopsy but subsequently propagated in human B-lymphoma cells and xenograft models. Unlike previously characterized EBV strains which are either predominantly B-lymphotropic or epitheliotropic, Yu103 evinces an uncanny capacity to infect and transform both B-lymphocytes and nasopharyngeal epithelial cells. Genomic and phylogenetic analyses indicated that Yu103 EBV lies midway along the spectrum of EBV strains known to drive lymphomagenesis or carcinogenesis, and harbors molecular features which likely account for its unusual properties. To our knowledge, Yu103 EBV is currently the only EBV isolate shown to drive human nasopharyngeal carcinoma and B-lymphoma, and should therefore provide a powerful novel platform for research on EBV-driven hematological and epithelial malignancies. | Source Title: | FRONTIERS IN ONCOLOGY | URI: | https://scholarbank.nus.edu.sg/handle/10635/206460 | ISSN: | 2234943X | DOI: | 10.3389/fonc.2021.626659 |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell .pdf | 4.09 MB | Adobe PDF | OPEN | Published | View/Download |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.